Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 28 Dec 2023 for Oncology Institute, Inc.. Read the official filing
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Maeve O'Meara: trading record in brief
Maeve O'Meara is a declared insider at 2 companies (chief executive); the most frequent names are Castlight Health, Inc. and Starling Oncology, Inc. Over a trading history stretching from 16 May 2021 to 26 December 2023, the count stands at 9 filings.
Not one of the filings records a straightforward purchase or sale on the market. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
The latest filing, published on 28 December 2023, reports a share grant in Starling Oncology, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Maeve O'Meara
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations9 total
50,000 shares0Common stockSEC:0001628280-23-042815:0
16,404 shares0Common stockSEC:0001628280-23-008829:0
22,708 shares0Common StockSEC:0001799191-22-000038:0
15,994 shares0Common stockSEC:0001628280-22-007100:0
1,625,989 sharesClass B Common StockSEC:0001209191-22-011149:0
12,500 shares0Class B Common StockSEC:0001209191-21-065650:0
5,000 sharesClass B Common StockSEC:0001209191-21-060117:0
12,500 shares0Class B Common StockSEC:0001209191-21-052086:0
12,500 shares0Class B Common StockSEC:0001209191-21-033727:0
9 of 9 declarations
